1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Malaria, Falciparum in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, TM; Graham, RM; Li, GQ; Spencer, JL; Sturm, M; Taylor, RR; Zhang, YR | 1 |
| Anh, TK; Binh, TQ; Davis, TM; Dyer, JR; St John, A; Sturm, M; van Phuong, N | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Malaria, Falciparum
| Article | Year |
|---|---|
Platelet-activating factor and lipid metabolism in acute malaria.
Topics: Acute Disease; Adolescent; Adult; Child; Cholesterol; Cholesterol, HDL; Female; Humans; Lipids; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Platelet Activating Factor; Triglycerides | 1993 |
The metabolism of platelet-activating factor in severe and cerebral malaria.
Topics: Adult; Antimalarials; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coma; Female; Humans; Intensive Care Units; Lipid Metabolism; Malaria, Cerebral; Malaria, Falciparum; Male; Middle Aged; Platelet Activating Factor; Vietnam; Western Australia | 1995 |